Expert Pitch
Florida State University

FSU professors available to comment on economic impact of coronavirus

6-Mar-2020 2:45 PM EST, by Florida State University

By: Mark Blackwell Thomas | Published: | 2:48 pm |  

As the coronavirus disease 2019 —or COVID-19— continues to spread, it disrupts world markets, supply chains and entire economies. As of March 5, nearly 100,000 people were confirmed infected and more than 3,000 deaths attributed to the disease.

The spread of coronavirus continues to create instability on a global scale. Given this changing landscape and its far-reaching implications, precise analysis and clear context are essential. Experts at Florida State University are ready to provide media with perspective and insights to help them fully understand and convey the consequences of coronavirus from the macro to micro levels.

Manoj Atolia, Bernard F. Sliger Professor of Economics, Department Chair

Atolia’s studies include development and international economics with an emphasis on the analysis of economic reforms and government policy in developing countries.

“I am an expert on macroeconomics and international economics and can address coronavirus’s implications for macroeconomic outcomes for the U.S. and for international trade and capital flows.”

April Knill, SunTrust Associate Professor of Finance, College of Business

Knill’s areas of expertise include international finance, politics and finance, law and entrepreneurship.

“The impact of the coronavirus on the economy is poised to be significant. The extent and the severity of the virus is still unknown. As such, employers are meeting coronavirus ‘with an abundance of caution’ through responses such as recommending employees stay home and limit travel, all of which can hurt workplace productivity. Consumers are limiting their exposure by avoiding stores or public gatherings, which affects aggregate demand. The full impact is yet to be realized but the Federal Reserve’s emergency rate cut is telling, as is the reaction of stock markets, the main indices of which have fallen more than 4 percent (as of March 4th). Only time will tell, but the country is bracing itself.”

 Nathaniel Line, associate professor, Dedman School of Hospitality

Line’s research experience includes demand shocks in the lodging industry and marketing environment, hospitality and tourism management and hospitality marketing.

“The impact of COVID-19 on the hospitality industry in the U.S. will ultimately depend on the extent and duration of the outbreak. The effects of the virus and subsequent responses by hospitality organizations will vary widely depending not only on the industry, such as lodging, restaurants and cruise lines, but also on market dynamics at the destination level. In the end, the real pathogen is not the virus itself, but the fear of the virus. The ultimate economic effects will depend on the ability of governments and public health organizations to contain and treat both.”

Larry Giunipero, professor, College of Business

Giunipero’s academic specialty is supply chain management and purchasing. His work also focuses on strategic sourcing, supply chain risk, global sourcing and technology applications.




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.21746